Replies to post #56463 on RespireRx Pharmaceuticals Inc (fka RSPI)

[Menace212]

That atleast eases me. Got 15k riding in this

[Dyno89]

Offer of settlement? So they did actually choose to let the SEC have them revoked? 
What a strange 2 years here...

[Menace212]

Where does it say offer of settlement in the link? What is it alluding to?

[crazy horse 0]

A while back I mentioned a stock dividend could happen, a reissue of shares in another company, a buyout of our common shares

What is a tender offer?

A public bid for shareholders to sell their holdings is a tender offer. A tender offer is a proposal that an investor offers to the stakeholders in a publicly traded business.
This process starts when the investor puts an advertisement, then an offer to buy is printed and mailed to the company’s shareholders

. A tender offer has many benefits such as: if a stock is sold for more than it was worth at that time, illiquid equity can be monetized, the proceeds can be used to exercise any remaining options you have for a more diverse portfolio, good tax treatment, pay your debt off, or save it for future. The tender offer must comply with the regulations of the SEC. Some of the rules are to include certain disclosure needs, manner of publication, withdrawal rights, and a minimum offering period.

A reminder "We are currently involved in several discussions in various stages of maturity with third-parties that are intended to result in any one of the following: (i) research collaborations, (ii) joint ventures, (iii) licenses or sublicenses and (iv) selective asset sales. If successful, of which no assurance can be provided, any of these may provide general and/or specific project funding, risk and reward sharing opportunities, in-kind support, infrastructure support, access to special skill sets and other benefits.

On January 25, 2025 we formed a single member, Delaware LLC that is a wholly-owned subsidiary named EndeavourRx LLC. We intend in the near future to via license, sublicence or otherwise, our neuromodulator program, in part or in its entirety. We believe that among other benefits, this creates a new viable financing vehicle. This would include the AMPAkines program and the GABAkines program in part or in whole.

In addition, we have recently signed a confidentiality agreement with an international pharmaceutical company about the possibility of in-licensing two compounds that would be synergistic with one of our programs."

Feb 10, 2025
Shareholder letter (PR'ed and also released as an 8-K) was released this morning.

https://finance.yahoo.com/news/respirerx-pharmaceuticals-inc-cfo-ceo-120000978.html

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175787285

[chrislal]

The Securities and Exchange Commission (“Commission”) deems it necessary and
appropriate for the protection of investors to accept the Offer of Settlement submitted by
RespireRx Pharmaceuticals Inc. (CIK No. 849636) (Ticker: RSPI) (“RSPI” or “Respondent”)
pursuant to Rule 240(a) of the Rules of Practice of the Commission, 17 C.F.R. §201.240(a), for
the purpose of settlement of these proceedings initiated against Respondent on September 11,
2025, pursuant to Section 12(j) of the Securities Exchange Act of 1934 (“Exchange Act”)



From reading this, looks like they accepted RSPI response and I think and hoping it will be good for all current shareholders but we definitely need explanation and details from RSPI,